EXENATIDE Safety Questions, EXENATIDE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about EXENATIDE. Our extensive database of EXENATIDE adverse events and EXENATIDE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about EXENATIDE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



EXENATIDE Safety Reports

Total EXENATIDE reports: 209.
EXENATIDE FDA safety alerts: 2007 .
   Reported hospitalizations: 9.
Take EXENATIDE Side Effects Survey or Share Your EXENATIDE Story. Read More Here.

Showing 1-75 of 209 Next >

Physician from UNITED STATES reported EXENATIDE problem on May 29, 2007. Female patient, 66 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: asthma, bronchial oedema, fatigue, nasal congestion, sinus congestion. EXENATIDE dosage: unknown. During the same period patient was treated with STRATTERA, GLIPIZIDE, AVANDIA, CLARITIN, SINGULAIR, SEREVENT, NASACORT, ALBUTEROL. Patient recovered.

EXENATIDE problem was reported by a Pharmacist from UNITED STATES on May 08, 2007. Male patient, 65 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. EXENATIDE dosage: unknown. During the same period patient was treated with ACTOS, GLUCOPHAGE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Mar 31, 2007. Female patient, 57 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased, dizziness, feeling jittery, injection site pain, mental impairment, nausea, tremor, vomiting. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLYBURIDE. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2007. Female patient, 51 years of age, weighting 149.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, contusion, eructation, fall, joint sprain, nausea, vomiting, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLIMEPIRIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Mar 31, 2007. Female patient, 59 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, epistaxis, influenza, injection site bruising. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLIPIZIDE, AVANDIA. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2007. Female patient was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. EXENATIDE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Mar 31, 2007. Male patient, 58 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. EXENATIDE dosage: unknown. During the same period patient was treated with GLIPIZIDE, METFORMIN. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2007. Female patient, 44 years of age, weighting 312.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, hypersensitivity, sinus disorder, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with JANUVIA, GLUMETZA, STARLIX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Mar 31, 2007. Female patient, 70 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased, nausea, vomiting. EXENATIDE dosage: unknown. During the same period patient was treated with GLIPIZIDE, ADANDAMETLET. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2007. Female patient, 63 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: injection site haemorrhage, nervousness. EXENATIDE dosage: unknown. During the same period patient was treated with LANTUS, GLYBURIDE, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Mar 31, 2007. Female patient, 35 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, nausea. EXENATIDE dosage: unknown. During the same period patient was treated with GLUCOPHAGE. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2007. Male patient, 70 years of age, weighting 289.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, nasopharyngitis, nausea, road traffic accident, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with LANTUS, PRANDIN, AVANDIA, METFORMIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 05, 2007. Male patient, 50 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. EXENATIDE dosage: unknown. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Female patient, 54 years of age, weighting 333.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, early satiety, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with HUMULIN N, HUMULIN R, TOPROL, VYTORIN, LEVOXYL, AVAPRO, LASIX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on June 06, 2007. Male patient, 55 years of age, weighting 240.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased, decreased appetite, tremor. EXENATIDE dosage: unknown. During the same period patient was treated with GLYBURIDE AND METFORMIN, DUETACT, JUNUVIA, ACTOS. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2007. Female patient, 75 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased, decreased appetite, diarrhoea, dizziness, hyperchlorhydria, nausea, vision blurred. EXENATIDE dosage: unknown. During the same period patient was treated with GLIPIZIDE, SYNTHROID, LISINOPRIL, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 05, 2007. Male patient, 50 years of age, weighting 246.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, dizziness, erythema, hypotension, nasopharyngitis, nausea. EXENATIDE dosage: unknown. During the same period patient was treated with INSULIN, ANTARA, ACTOPLUSLET, MICARDIS. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Male patient, 60 years of age, weighting 218.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: weight decreased. EXENATIDE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on May 08, 2007. Male patient, 75 years of age, weighting 319.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: constipation, diarrhoea, dyspepsia, nausea, weight decreased. EXENATIDE dosage: unknown. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2007. Female patient, 73 years of age, weighting 138.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood glucose decreased, blood glucose increased, decreased appetite, diarrhoea, dizziness, flatulence, hypoglycaemia, nausea. EXENATIDE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 21, 2007. Female patient, 44 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: dizziness, malaise, nausea. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, LANTUS, LYRICA. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 25, 2007. Female patient, 67 years of age, weighting 197.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, decreased appetite, diplopia, dizziness, dyspepsia, nausea, somnolence, stomach discomfort, vision blurred. EXENATIDE dosage: unknown. During the same period patient was treated with EXANATIDE, GLUCOPHAGE, AVANDIA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 10, 2007. Female patient, 64 years of age, weighting 300.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspepsia, dyspnoea, headache, nausea, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with BLOOD PRESSURE MEDICINE. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Female patient, 67 years of age, weighting 246.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, decreased appetite, injection site bruising, nausea, weight decreased, wound. EXENATIDE dosage: unknown. During the same period patient was treated with EXENATIDE PEN, METFORMIN, GLYBURIDE AND METFORMIN, ACTOS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 12, 2007. Male patient, 53 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, injection site pain, weight decreased. EXENATIDE dosage: unknown. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 07, 2007. Female patient, 64 years of age, weighting 222.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, injection site bruising, injection site haemorrhage, injection site pain, nausea, vomiting, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with LANTUS, GLUCOPHAGE, EXENATIDE PEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 12, 2007. Female patient, 78 years of age, weighting 177.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: anorexia, blood glucose increased. EXENATIDE dosage: unknown. During the same period patient was treated with AVANDIA, GLUCOPHAGE, GLUCOTROL, METFORMIN, TRICOR. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Female patient, 57 years of age, weighting 156.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood glucose decreased, chills, feeling abnormal, feeling cold, hyperhidrosis, nausea. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLYBURIDE, GLIPIZIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on June 18, 2007. Female patient, 67 years of age, weighting 237.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with GLIPIZIDE, ACTOS, METFORMIN. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2007. Male patient, 69 years of age, weighting 330.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, glycosylated haemoglobin increased. EXENATIDE dosage: unknown. During the same period patient was treated with HUMULIN, METFORMIN, ACTOS, ASPIRIN, DIOVAN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 12, 2007. Female patient, 78 years of age, weighting 220.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, pruritus, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with LANTUS. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, 77 years of age, weighting 171.5 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: arthralgia, arthritis, decreased appetite, myalgia, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLIMEPIRIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on May 14, 2007. Female patient, 55 years of age, was diagnosed with diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, decreased appetite, early satiety, hunger. EXENATIDE dosage: unknown. During the same period patient was treated with EXENATIDE PEN. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Male patient, 76 years of age, weighting 228.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: anorexia, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with EXENATIDE PEN, INSULIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 04, 2007. Female patient, 66 years of age, weighting 200.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose decreased, blood glucose increased, constipation, diarrhoea, nausea, tremor, viral infection, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with GLYBURIDE, GLYBURIDE AND METFORMIN. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Female patient, 64 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose fluctuation, blood glucose increased, incorrect dose administered, injection site bruising, injection site extravasation, injection site haemorrhage, nervousness. EXENATIDE dosage: unknown. During the same period patient was treated with ACTOS, GLYBURIDE, GLUCOPHAGE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on May 14, 2007. Male patient, 47 years of age, weighting 330.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, decreased appetite, headache, hypoglycaemia, nausea, tremor, tunnel vision, vision blurred. EXENATIDE dosage: unknown. During the same period patient was treated with LANTUS, GLUCOTROL, METFORMIN, ACTOS. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2007. Male patient, 58 years of age, weighting 250.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, incorrect dose administered, night sweats, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLUCOPRIDE, AVANDIA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 06, 2007. Female patient, 63 years of age, weighting 179.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood glucose decreased, blood glucose increased, confusional state, diarrhoea, dizziness, feeling cold, nausea, tremor. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLUCOTROL. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2007. Female patient, 71 years of age, weighting 190.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: asthenopia, eructation, nausea, ocular discomfort, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with ACTOS, EXENATIDE PEN. Patient recovered.

Physician from UNITED STATES reported EXENATIDE problem on Apr 30, 2007. Female patient, 56 years of age, weighting 250.0 lb, was diagnosed with weight decreased and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood parathyroid hormone increased, blood urea increased, decreased appetite, injection site extravasation, nausea, renal failure, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with EXENATIDE PEN, ZAROXOLYN, BUMEX, DRISDOL, SENSIPAR, TRICOR, LIPITOR. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient, 73 years of age, weighting 153.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: chills, dizziness, gait disturbance, lice infestation, urticaria, vision blurred, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with GLUCOTROL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on May 31, 2007. Female patient, 63 years of age, weighting 117.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased, diarrhoea, dizziness, fall, feeling abnormal, gait disturbance, nervousness, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with FLURAZEPAM, EFFEXOR, AMARYL, METFORMIN. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Male patient, 67 years of age, weighting 216.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, cold sweat, decreased appetite, dizziness, dyspepsia, dysphagia, feeling hot, hiatus hernia, malaise. EXENATIDE dosage: unknown. During the same period patient was treated with BYETTA, METFORMIN, ACTOS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on May 01, 2007. Male patient, 63 years of age, weighting 257.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: constipation, diarrhoea, dyspepsia, flatulence, hypersensitivity, injection site bruising, injection site erythema, nausea, oesophageal pain. EXENATIDE dosage: unknown. During the same period patient was treated with AVANDIA, LOTENSIN, PRILOSEC, HYDROCHLOROTHIAZIDE, TOPROL, NORVASC, PLAVIX, LIPITOR. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2007. Female patient, 60 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: anorexia, anxiety, asthenia, fatigue, nasopharyngitis, nausea, nervousness, paraesthesia oral. EXENATIDE dosage: unknown. During the same period patient was treated with GLUCOVANCE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on May 10, 2007. Male patient, 59 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased, international normalised ratio increased. EXENATIDE dosage: unknown. During the same period patient was treated with PAXIL, COUMADIN, TESTOSTERONE. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Female patient, 66 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: adverse event, back pain, blood glucose decreased, decreased appetite, diarrhoea, dizziness, influenza like illness, injection site haemorrhage, nausea. EXENATIDE dosage: unknown. During the same period patient was treated with STARLIX, AVANDIA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 19, 2007. Female patient, 53 years of age, weighting 140.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, chills, dizziness, early satiety, injection site haemorrhage, injection site pain, injection site rash, malaise, nausea. EXENATIDE dosage: unknown. During the same period patient was treated with GLYBURIDE, AMARYL, SYNTHROID, VITAMIN D. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Female patient, 67 years of age, weighting 207.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, fatigue, injection site bruising, injection site erythema, injection site haemorrhage, paraesthesia oral, rash, thirst, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with STEROIDECTION, AVANDIA, AMARYL, GLUCOPHAGE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 18, 2007. Male patient, 65 years of age, weighting 308.0 lb, was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, decreased appetite, headache, stomach discomfort, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with NOVOLOGECTION, LANTUS, ACTOS. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Male patient, 76 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased. EXENATIDE dosage: unknown. During the same period patient was treated with ACTOS, GLYNASE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 13, 2007. Male patient, 59 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: increased appetite, nausea. EXENATIDE dosage: unknown. During the same period patient was treated with AMARYL, AVANDAMET. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Female patient, 64 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, blood glucose decreased, blood glucose increased, decreased appetite, disorientation, flushing, urine output decreased. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLIPIZIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on June 18, 2007. Male patient, 58 years of age, weighting 212.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased, decreased appetite, depressed mood, fatigue, nausea. EXENATIDE dosage: unknown. During the same period patient was treated with AVANDIA, GLIPIZIDE, METFORMIN. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Female patient, 63 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased, blood pressure increased, early satiety, frequent bowel movements, hyperhidrosis, pruritus, swelling face, tremor. EXENATIDE dosage: unknown. During the same period patient was treated with ACTOS, GLIPIZIDE, PLAVIX, GLUCOPHAGE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on May 17, 2007. Female patient, 64 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: anorexia, weight increased. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 07, 2007. Female patient, 71 years of age, weighting 215.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood glucose increased, decreased appetite, early satiety, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, AVANDIA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 11, 2007. Female patient, 64 years of age, weighting 235.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, injection site urticaria, nausea, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with GLUCOPHAGE, TRICOR, ACE INHIBITOR, VYTORIN, AVANDIA. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2007. Male patient, 44 years of age, weighting 289.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose abnormal. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLYBURIDE, LANTUS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 25, 2007. Female patient, 50 years of age, weighting 194.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, blood glucose increased. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLIPIZIDE, GLYBURIDE, STARLIX. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2007. Female patient, 58 years of age, weighting 224.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, glycosylated haemoglobin increased, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with INSULIN, AVANDIA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on June 06, 2007. Male patient, 73 years of age, weighting 212.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: nausea, therapeutic response unexpected, vomiting. EXENATIDE dosage: unknown. During the same period patient was treated with AVANDIA, METFORMIN, ACTOS. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Female patient, 71 years of age, weighting 156.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood glucose decreased, blood glucose increased, diarrhoea, flatulence, hyperhidrosis, injection site bruising, injection site haemorrhage, nausea. EXENATIDE dosage: unknown. During the same period patient was treated with GLYBURIDE, PRECOSE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 04, 2007. Male patient, 40 years of age, weighting 175.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: alopecia, chapped lips, dizziness, erythema, gingival pain, headache, hypotrichosis, lip dry, madarosis. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, AMARYL. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Male patient, 59 years of age, weighting 233.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: amnesia, condition aggravated, grip strength decreased, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with GLUCOPHAGE, CHOLESTYRAMINE, ZETIA, GLIMEPIRIDE, LISINOPRIL. Patient recovered.

Health Professional from UNITED STATES reported EXENATIDE problem on June 22, 2007. Female patient, 66 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, eructation, fatigue, insomnia, nausea, pain, pollakiuria, somnolence, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with PRANDIN, METFORMIN, ALBUTEROL, INTAL, AZMACORT. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Female patient, 68 years of age, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. EXENATIDE dosage: unknown. During the same period patient was treated with LANTUS, METFORMIN, GLYBURIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on May 22, 2007. Female patient, 52 years of age, weighting 250.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased, constipation, depression, dysgeusia, eructation, fatigue, headache. EXENATIDE dosage: unknown. During the same period patient was treated with GLYBURIDE, AMARYL. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Female patient, 53 years of age, weighting 289.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, heart rate irregular, hypertension, myocardial infarction, urinary tract infection, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with ACTOS, GLUCOPHAGE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on June 11, 2007. Female patient, 60 years of age, weighting 151.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, headache, increased appetite, therapeutic response unexpected, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLIMEPIRIDE. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, 60 years of age, weighting 254.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, increased appetite, injection site induration, injection site urticaria, nausea, therapeutic response unexpected, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with LANTUS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on May 29, 2007. Female patient, 54 years of age, weighting 226.0 lb, was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: anorexia, diarrhoea, dysgeusia, energy increased, hot flush, infrequent bowel movements, insomnia, nausea, suicidal ideation. EXENATIDE dosage: unknown. During the same period patient was treated with GLUCOPHAGE, METFORMIN. Patient recovered.

EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 27, 2007. Male patient, 70 years of age, weighting 192.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, decreased appetite, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, GLYBURIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on May 29, 2007. Female patient, 59 years of age, weighting 110.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, blood glucose increased, decreased appetite, nausea, weight decreased. EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, ACTOS. Patient recovered.

Showing 1-75 of 209 Next >

Ask Our Patient Community about EXENATIDE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert